Vikram Shanbhag_HealthcareConsults

3/3 In the US, “Doctor” is broad—physicians, pharmacists, PhDs all use it. India’s challenge is unique: clarity vs. recognition. So, where do you stand? 👉 Should “Dr.” stay exclusive or be more inclusive? Drop your thoughts 👇 #Healthcare #Policy #India @NMC_IND

One of #SiliconBeach’s promising (hardware) startup is looking for 1000 sqft of space in industrial area (Manipal, Baikampady, Yeyyadi) to build high-tech containers as they recently landed an order for multiple containers. Anyone here who can help out? RT for good karma

Community health centers are reporting benefits from value-based contracts yet face significant barriers in accountable care participation. Harris Meyer delves into the complexities surrounding their future in accountable care arrangements. healthaffairs.org/doi/full/10.13…

Is it possible to describe what agentic AI is and what it might mean in healthcare in less than a minute? Let's see!

🧵5/ Final thought: In clinical trials, speed decides winners. And AI is no longer just assisting the process—it’s redefining the trial itself. From protocol to patient, the future is being screened by AI. 🧠⚡ #AIHealthFrontier #HealthInnovation #FutureOfHealthcare

🧵3/ The bigger signal isn’t the model. It’s the strategy. A leading health system has turned internal AI into a scalable company—shifting from: Cost center ➝ Capability ➝ Enterprise value That’s a textbook operating-model upgrade. #DigitalTransformation #AIinHealthcare

🧵1/ Most clinical trials don’t fail on science. They fail on execution. Patient identification alone drives ~30% of trial costs, slowed by manual chart reviews and fragmented EHRs. That bottleneck just met its match. 👇 #AIHealthFrontier #ClinicalTrials

Post 4 But the conference’s most electric moment? @intelliatx NTLA-2002 gene-editing program — early data suggesting long-term attack suppression from a single dose. If larger trials hold, it could become the first functional cure in HAE. The market is evolving fast

Post 3 In on-demand therapy, @KalVista Ekterly (sebetralstat) stands out as the first oral ODT for acute HAE attacks. This directly challenges the injectable-heavy landscape, positioning oral agents as the next competitive frontier. #ODT #Ekterly

Post 1 Did ACAAI 2025 just reset the competitive map for Hereditary Angioedema (HAE)? That is the biggest takeaway coming out of @citybeautiful last month. Three new launches are rewriting the rules — and expanding what “standard of care” could mean. #HAE #ACAAI2025 #Pharma

5/ As PBMs, pharma, and employers juggle affordability vs. access, formularies have evolved from drug lists into strategic control documents. In US market access, the rule is simple: The drug with the tier wins — not the drug with the data. #DrugPricing #AccessToMedicines

4/ Example: A commercial plan may keep Humira on Tier 3 while placing Amjevita (biosimilar) on Tier 2 in a closed formulary. One tier change → instant movement in patient share, payer economics, and contracting leverage. #Biosimilars #Pharma

🧵1/ Ever wondered why two patients with the same prescription pay completely different out-of-pocket costs? Welcome to the world of US formularies — the quiet architects of drug access. #MarketAccess #USHealthcare

4/4 A big accelerator is the KHZG — Germany’s €4.3B hospital digital-modernisation law, funding EHRs, portals, telemedicine and IT security, tied to strict maturity targets. Germany has the tech and the talent. What it needs now is scale and consistency. #HealthInnovation #KHZG

3/4 What’s moving the system forward: @CompuGroupMedical, @SiemensHealth , @doctolib , @SAP are strengthening interoperability and workflow digitisation. And service partners like @Cognizant , @Infosys , @TCS are embedding cloud, FHIR and automation across provider networks.

🧵 Thread: Germany’s Digital Health Paradox 1/4 47% of German hospitals still sit below “advanced” digital maturity — surprising for Europe’s largest healthcare market. EHR adoption is strong, privacy frameworks are world-class, yet digital performance remains uneven. #Germany